An allosteric site in the T-cell receptor Cβ domain plays a critical signalling role.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28508865.
- Also identified by DOI 10.1038/ncomms15260 and PMC identifier 5440810.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The molecular mechanism through which the interaction of a clonotypic αβ T-cell receptor (TCR) with a peptide-loaded major histocompatibility complex (p/MHC) leads to T-cell activation is not yet fully understood. Here we exploit a high-affinity TCR (B4.2.3) to examine the structural changes that accompany binding to its p/MHC ligand (P18-I10/H2-D<sup>d</sup>). In addition to conformational changes in complementarity-determining regions (CDRs) of the TCR seen in comparison of unliganded and bound X-ray structures, NMR characterization of the TCR β-chain dynamics reveals significant chemical shift effects in sites removed from the MHC-binding site. Remodelling of electrostatic interactions near the Cβ H3 helix at the membrane-proximal face of the TCR, a region implicated in interactions with the CD3 co-receptor, suggests a possible role for an allosteric mechanism in TCR signalling. The contribution of these TCR residues to signal transduction is supported by mutagenesis and T-cell functional assays.
Medical subject headings
- Allosteric Site
- Complementarity Determining Regions
- Receptors, Antigen, T-Cell, alpha-beta
- Signal Transduction
- T-Lymphocytes